Chromatography and filtration reagents market set for double-digit growth through 2030
The Business Research Company says the global chromatography and filtration reagents market will rise from $6.75 billion in 2025 to $12.29 billion by 2030, fueled by biologics testing, lab automation and stricter monitoring rules. North America leads now, but Asia-Pacific is expected to grow fastest as biotech and pharma investment expands.
Why it matters: - Chromatography and filtration reagents are core inputs for separation, purification and analysis in pharmaceuticals, research and environmental monitoring. - The market’s growth points to rising demand for quality control, advanced testing and scalable lab workflows across life sciences and industrial applications. - The report signals where lab spending is likely to concentrate next, especially in biologics, genomics and automated testing.
What happened: - The Business Research Company published a 2026 market report on chromatography and filtration reagents with a forecast through 2035. - The market is projected to grow from $6.75 billion in 2025 to $7.59 billion in 2026. - The report projects the market will reach $12.29 billion by 2030. - The company gives the market a 12.6% CAGR for the 2025-2026 period and 12.8% CAGR for the forecast period through 2030. - North America was the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period.
The details: - Historical growth has been supported by demand for pharmaceutical quality control testing, expansion of research and academic labs, generic drug manufacturing, analytical testing in food safety and standardized chromatography methods. - Future growth is expected to come from biologics and biosimilar testing, genomics, personalized medicine, biomarker analysis, stricter environmental monitoring rules and automated, high-throughput lab systems. - The report highlights wider use of HPLC and UHPLC consumables, advanced membrane filtration technologies, environmentally friendly chromatography solvents, automated sample preparation systems and digital analytics in separation workflows. - Chromatography and filtration reagents include solvents, buffers, adsorbents, membranes and other specialty compounds used in separation and purification. - These reagents support precision, consistency and reliability in laboratory testing, research and industrial production. - The report says one major growth driver is biopharmaceutical and biologic production, including monoclonal antibodies, vaccines and recombinant proteins. - In October 2025, UK government statistics showed life sciences manufacturing turnover reached $61.57 billion (£46.5 billion) in 2023–2024, equal to 32% of total sector turnover. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa.
Between the lines: - The forecast suggests chromatography and filtration are becoming less like commodity lab inputs and more like enabling infrastructure for regulated, high-volume biology and diagnostics work. - The move toward automation and digital analytics reflects pressure to speed up workflows while maintaining reproducibility and compliance. - Asia-Pacific’s growth outlook likely reflects broader industrial buildout in pharma and biotech, while North America remains the current center of demand.
What's next: - The market is expected to keep expanding as biologics testing, precision medicine and environmental oversight create more demand for separation and purification tools. - Vendors are likely to compete more on automation, membrane performance, solvent sustainability and workflow integration. - The report points to continued demand for forecasting tools, market scoring and technology trend analysis as companies track where growth is moving. - More information is available in the full report and a free sample.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
The Europe Daily Report
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.